Bibliografía - International Union Against Cancer

Bibliografía
1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risk to humans,
Vol 59, Hepatitis viruses. Lyon: IARC Press; 1995.
2. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans,
Vol 61, Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC Press; 1994.
3. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans,
Vol 64, Human papillomaviruses, Lyon: IARC Press; 1995.
4. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans,
Vol 67, Human immunodeficiency viruses and human T-cell lymphotropic viruses, Lyon: IARC Press; 1996.
5. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans,
Vol 70, Epstein-Barr virus and Kaposi sarcoma herpes virus/human herpes virus 8, Lyon: IARC Press; 1997.
6. Pisani P, Parkin DM, Muñoz N et al. Cancer and infection: estimates of the attributable fraction in 1990. Cancer
Epidemiol Biomarkers Prev. 1997;6:387-400.
7. Parkin DM, Pisani P, Muñoz N et al. The global health burden of infection associated cancers. En: Weiss RA, Beral V,
Newton R (eds). Cancer surveys, Vol 33, Infections and human cancer. Cold Spring Harbor, NY: CSH Press; 1998.
8. Ferlay, Bray F, Parkin DM et al. GLOBOCAN 2002, IARC Cancer Base No 5, Lyon: International Agency for Research on Cancer.
http://www-dep.iarc.fr/globocan/methods.htm - http://caonline.amcancersoc.org/cgi/content/full/55/2/74#TBL1
9. UNAIDS (2000) Report on the global HIV/AIDS epidemic. www.who.org
10. Labrecque D. Neoplasias of the liver. En: Kapliwitz Neil (eds.) Liver and Biliary Diseases. Baltimore: Williams & Wilkins;
1992. p.347-63.
11. Leuschner I, Harás D, Schmidt D. The association of hepatocellular carcinoma with hepatitis B virus infection in childhood.
Cancer. 1998;62:2363-9.
12. Farfán G. Epidemiología de la hepatitis viral en el Perú. Revista Peruana de Epidemiología. 1990;3(2):43-55.
13. Ruiz E, Almonte M, Pizarro R et al. Infección con virus de la hepatitis B y hepatitis C como factores de riesgo para
hepatocarcinoma en el Perú: estudio de casos y controles. Rev Gastroenter Perú. 1998,(18):199-212.
14. Chang M et al. Hepatitis B vaccination of infants in Taiwan and incidence of HCC in children age 6-14. N Engl J Med.
1997;336:1855-9.
15. Lee MS, Kim DH, Kim H et al. Hepatitis vaccination and reduced risk of primary liver cancer among male adults: a
cohort study in Korea. Int J Epidemiol. 1998;27:316-9.
16. World Health Organization. WHO Expanded Programme on Immunization. www.who.org. Geneva: World Health
Organization.
17. Namgyal P, Impact of hepatitis B immunization, Europe and worldwide. J Hepatol. 2003;39(Suppl. 1):S77-82.
18. Vryheid RE, Kane MA, Muller N et al. Infant and adolescent hepatitis B immunization up to 1999: a global overview.
Vaccine. 2000;19:1026-37.
19. Alter MJ. Prevention of spread of hepatitis C. Heptatology. 2002;36(5 Suppl. 1):S93-8.
20. zur Hausen H. Papilloma virus infections: a major cause of human cancers. Biochem Biophys Acta. 1996;1288:F55-78.
21. Muñoz N, Bosch FX, de Sanjosé S et al. Epidemiology classification of human papillomavirus types associated with
cervical cancer. N Eng J Med. 2003:348:518-27.
22. Santos C, Muñoz N, Kleng S et al. HPV types and cofactors causing cervical cancer in Peru. British Journal of Cancer.
2001;85(7):966-71.
PREVENCION DEL CANCER: ESTRATEGIAS BASADAS EN LA EVIDENCIA
Una guía de la UICC para América Latina
INFECCIONES
217